Does ATOGEPANT Cause Gait inability? 15 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Gait inability have been filed in association with ATOGEPANT (Qulipta). This represents 0.3% of all adverse event reports for ATOGEPANT.
15
Reports of Gait inability with ATOGEPANT
0.3%
of all ATOGEPANT reports
0
Deaths
4
Hospitalizations
How Dangerous Is Gait inability From ATOGEPANT?
Of the 15 reports, 4 (26.7%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATOGEPANT. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does ATOGEPANT Cause?
Migraine (908)
Drug ineffective (581)
Headache (497)
Nausea (453)
Constipation (376)
Fatigue (282)
Dizziness (192)
Therapy interrupted (175)
Decreased appetite (127)
Therapeutic product effect incomplete (125)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which ATOGEPANT Alternatives Have Lower Gait inability Risk?
ATOGEPANT vs ATOMOXETINE
ATOGEPANT vs ATOMOXETINE\ATOMOXETINE
ATOGEPANT vs ATORVASTATIN
ATOGEPANT vs ATORVASTATIN\EZETIMIBE
ATOGEPANT vs ATOSIBAN